Company Overview More
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd.; Catalent Inc., Laboratorios Farmacéuticos Rovi, S.A., Recipharm, and Lonza Group; Aldevron, LLC; Institute for Life Changing Medicines; and AbCellera Biologics Inc. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
CEO: --
Market: NASDAQ
Futu Hot List
USHKCN
Trade HeatSearch HeatNews Heat
SymbolLatest Price% Chg

Loading...

Moomoo > Quotes > MRNA Moderna > Detailed Quotes

MRNA Moderna

408.840-21.300-4.95%
Close 09/27 18:33 ET
408.400-0.44-0.11%
Post Mkt Price 09/27 18:51 ET
High
434.000
Open
430.601
Turnover
5.52B
Low
407.255
Prev.Close
430.140
Volume
13.33M
Market Cap
165.03B
P/E(TTM)
51.11
52Wk High
497.490
Shares
403.65M
P/E
Loss
52Wk Low
65.490
H Mkt Cap
139.35B
Bid-Ask Ratio
-91.67%
Historical High
497.490
H Shares
340.84M
Vol. Ratio
1.23
Historical Low
11.540
Dividend TTM
--
Div Yield TTM
150
P/B
24.62
Dividend LFY
--
Div Yield LFY
36.69%
Turnover Ratio
3.91%
Amplitude
6.22%
Avg Price
414.008
Min Trading Unit
1
Float Market Cap
139.35B
Bid-Ask Ratio
-91.67%
Historical High
497.490
Float
340.84M
Vol. Ratio
1.23
Historical Low
11.540
Dividend TTM
--
P/B
24.62
Dividend LFY
--
Turnover Ratio
3.91%
Amplitude
6.22%
Avg Price
414.008
Min Trading Unit
1
Price Forecast

Loading...

News